Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Summary
This study is dedicated to addressing the lack of research on the most effective dosage of long-acting growth hormone for children with short stature. By employing clinical trial design, we are committed to investigating the therapeutic benefits and safety profiles associated with varying doses of long-acting growth hormone. Our ultimate goal is to offer clinicians more precise treatment guidance and assist patients in attaining optimal growth and developmental outcomes.
Key Details
Gender
All
Age Range
1 Year - 16 Years
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2025-01-15
Completion Date
2027-06-01
Last Updated
2025-01-10
Healthy Volunteers
No
Conditions
Interventions
PEG-rhGH
1= 0.2mg/kg/week Initial doses of PEG-rhGH 2=0.22mg/kg/week Initial doses of PEG-rhGH
GnRHa
1. pubertal children of short stature without GnRHa treatment 2. pubertal children of short stature with GnRHa treatment